Published in Arch Surg on January 01, 1971
A case of needle ingestion in a female - laparoscopic retrieval. JSLS (2008) 1.26
Recurrent appendicitis following successful conservative management of an appendicular mass in association with a foreign body: a case report. Cases J (2009) 1.18
Appendiceal colic in childhood: the role of inspissated casts of stool within the appendix. Ann Surg (1980) 0.97
Ingested metallic foreign body lodged in the appendix. J Indian Assoc Pediatr Surg (2011) 0.94
Can fruit seeds and undigested plant residuals cause acute appendicitis. Asian Pac J Trop Biomed (2011) 0.88
Removal of retained lead shot through laparoscopic appendectomy. JSLS (2003) 0.86
Crohn's disease of the appendix. Can Med Assoc J (1972) 0.86
Fishbone-induced perforated appendicitis. BMJ Case Rep (2015) 0.78
Foreign body in the appendix presenting as acute appendicitis: a case report. J Med Case Rep (2016) 0.75
Acute contact appendicitis due to a migrated pericardial drain: a case report. Cases J (2009) 0.75
Appendicular foreign body presenting with appendicular mass. Ci Ji Yi Xue Za Zhi (2016) 0.75
A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol (1981) 8.17
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol (1999) 3.74
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 3.41
Minimal size plasmids containing an M13 origin for production of single-strand transducing particles. J Mol Appl Genet (1984) 3.01
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg (1978) 2.94
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery (1979) 2.65
Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability. J Immunol (1982) 2.63
Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer (1979) 2.41
Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibody. J Exp Med (1982) 2.35
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19
Aneurysms and pseudoaneurysms of the superficial temporal artery caused by trauma. J Vasc Surg (1988) 2.17
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg (1981) 2.09
Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells. J Immunol (1985) 2.03
Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum (2009) 2.03
Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J Exp Med (1988) 1.98
Parental presence during induction of anesthesia. A randomized controlled trial. Anesthesiology (1996) 1.95
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol (1998) 1.92
Recent advances in the care of the patient with malignant melanoma. Ann Surg (1997) 1.92
No safe haven. II: The effects of violence exposure on urban youth. J Am Acad Child Adolesc Psychiatry (1999) 1.71
The prognostic significance of ulceration of cutaneous melanoma. Cancer (1980) 1.66
Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg (1982) 1.62
Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody. J Immunol (1983) 1.60
Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol (1998) 1.57
Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology (Oxford) (2001) 1.54
Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. Cancer Res (1986) 1.50
BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. Cancer Res (1999) 1.48
Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life. J Exp Med (1983) 1.48
Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol (1996) 1.48
A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol (1983) 1.46
A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg (1983) 1.45
Corynebacterium parvum versus bacille Calmette-Guérin adjuvant immunotherapy of stage II malignant melanoma. J Clin Oncol (1991) 1.42
The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg (1989) 1.41
What is a surgical oncologist? Ann Surg Oncol (1994) 1.40
How patient referral bias can confuse interpretation of clinical results: elective lymph node dissections at the Sydney Melanoma Unit. J Am Coll Surg (1995) 1.39
Prognostic histopathological factors in malignant melanoma. Pathology (1985) 1.39
The needle biopsy should replace open excisional biopsy ... but will the surgeon's role in coordinating breast cancer treatment be diminished? Ann Surg Oncol (1995) 1.39
Think melanoma. South Med J (1993) 1.39
Characterization of HNK-1+ (Leu-7) human lymphocytes. II. Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells. J Immunol (1982) 1.38
Spontaneous common carotid artery dissection. J Vasc Surg (1993) 1.37
Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions. J Biol Chem (1998) 1.34
Isolation and partial characterization of the human homologue of Thy-1. J Exp Med (1980) 1.34
Surgery for abdominal metastases of cutaneous melanoma. World J Surg (2001) 1.33
Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol (1998) 1.29
Serosal hypofibrinolysis. A cause of postoperative adhesions. Am J Surg (1973) 1.28
Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition. Ann Thorac Surg (1992) 1.27
Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases. Gastroenterology (1983) 1.26
Survival following locoregional recurrence after breast conservation therapy for cancer. Ann Surg (1990) 1.25
The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer (1985) 1.24
Spontaneous arterial perforation: the Ehlers-Danlos specter. J Vasc Surg (1987) 1.23
Effect of heparin on the fibrinolytic system. Surg Forum (1966) 1.23
Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease. Gastroenterology (1984) 1.22
Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol (1996) 1.21
Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol (1993) 1.19
Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer (1983) 1.18
The biology of cancer metastasis and implications for therapy. Curr Probl Surg (1987) 1.18
Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obstet (1973) 1.18
Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults. Eur J Immunol (1984) 1.17
Predicting survival and recurrence in localized melanoma: a multivariate approach. World J Surg (1992) 1.16
Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures. Surg Gynecol Obstet (1984) 1.15
Low levels of dopamine beta-hydroxylase and psychosis. Am J Psychiatry (1977) 1.14
Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg (1989) 1.12
Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. A feasibility study in 50 patients. Am J Surg (1983) 1.12
Economic impact of reducing hospitalization for mastectomy patients. Ann Surg (1988) 1.12
Mood variability in adolescents: a study of depressed, nondepressed and comorbid patients. J Affect Disord (1991) 1.12
Spectrum of pulmonary sequestration. Ann Thorac Surg (1976) 1.11
Surgical management of regional lymph nodes in cutaneous melanoma. J Am Acad Dermatol (1980) 1.10
A comparison of PGE2 effects on human suppressor cell function and on interleukin 2 function. J Immunol (1982) 1.10
Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer. Cold Spring Harb Symp Quant Biol (2005) 1.10
Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol (2001) 1.10
Ethnic differences in the lymphocyte proliferative response induced by a murine IgG1 antibody, Leu-4, to the T3 molecule. J Exp Med (1984) 1.09
Surgical management and prognostic factors in patients with subungual melanoma. Ann Surg (1994) 1.09
Assessment of percutaneous balloon pulmonary and aortic valvuloplasty. J Thorac Cardiovasc Surg (1984) 1.08
Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells. J Immunol (1987) 1.07
Cross-reactive T-cell antigens among mammalian species. J Immunol (1976) 1.07
A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann Surg (1983) 1.06
Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity. Ann Surg (1991) 1.05
Malignant melanoma. Arch Pathol Lab Med (2001) 1.04
Interleukin 2 receptor expression by activated HNK-1+ granular lymphocytes: a requirement for their proliferation. J Immunol (1983) 1.03
Health promotion in the city: a structured review of the literature on interventions to prevent heart disease, substance abuse, violence and HIV infection in US metropolitan areas, 1980-1995. J Urban Health (2000) 1.03
Heparin-induced thrombocytopenia, thrombosis, and hemorrhage. Ann Surg (1983) 1.02
Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients. Surgery (1984) 1.01
Detection of human T cells using anti-monkey thymocyte antisera. Tissue distribution and evidence for antigenic heterogeneity. Clin Immunol Immunopathol (1977) 1.01
Biliary tract disorders and sickle cell disease. Surgery (1972) 1.01
Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology. J Clin Invest (1982) 1.00
Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial. J Am Coll Surg (1998) 1.00
Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. Am J Physiol (1996) 0.99
A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease. Neurology (2008) 0.99
Site-specific mutagenesis of the nodule-infected cell expression (NICE) element and the AT-rich element ATRE-BS2* of the Sesbania rostrata leghemoglobin glb3 promoter. Plant Cell (1994) 0.99
Lysis of human solid tumor cells by lymphokine-activated natural killer cells. J Immunol (1986) 0.98
Arterial injury associated with fractures. Arch Surg (1966) 0.98
Lower extremity edema from bladder compression of the iliac veins. J Vasc Surg (1988) 0.97
The role of surgery in sickle cell disease. Surg Gynecol Obstet (1973) 0.97
Thymus-dependent lymphocytes in tissue sections of rejecting rat renal allografts. J Exp Med (1973) 0.96
Effect of pentoxifylline on tissue injury and platelet-activating factor production during ischemia-reperfusion injury. J Vasc Surg (1995) 0.96
Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia. Cancer (1983) 0.96
Thymus-dependent (T) lymphocytes in the rat. J Immunol (1974) 0.96
1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol (2000) 0.95